Abstract
Background and Aims : Auto-antibodies against apolipoprotein A-1 (AAA1) develop during SARS-CoV-2 infection and could be of concern as mediators of symptoms in the later stages of infection. We aimed at determining i) the duration and kinetics of AAA1 response over 12 months after a SARS-CoV-2 infection, and ii) whether AAA1 were associated with COVID-19 symptoms persistence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
